Biler A, et al. – This report outlined the clinicopathological characteristics, treatment, survival, and prognosis of endometrial cancer in women aged ≤40 years. Evidence suggested that a cancer antigen 125 level ≥ 35 was the only independent prognostic factor for both progression–free survival and overall survival in these patients.